Financials

  • Market Capitalization 599.67 M
  • Employee 200
  • Founded 2015
  • CEO N/A
  • Website www.ars-pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00FZQGXG3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-6.7
Rapporto prezzo/fatturato
13.63

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2796
RGNX
REGENXBIO Inc. - Common Stock
9.37 USD-0.11%-15.89%-2.90%-30.23%618.54 M USD
2814
ARVN
Arvinas, Inc. - Common Stock
9.24 USD-0.86%+2.44%+12.96%-0.65%604.17 M USD
2838
CAPR
Capricor Therapeutics, Inc. - Common Stock
10.06 USD+7.48%+47.94%+227.69%+60.19%584.88 M USD
2841
ARTV
Artiva Biotherapeutics, Inc. - Common Stock
11.94 USD+1.44%+6.04%+11.69%+187.02%583.75 M USD

Notizie